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Abstract
The causes of over-expression for many diseases are typ-
ically unknown, but current studies show that copy number
aberrationsmaybe strongcandidatesfordrivinggeneover-
expression. We present the use of the generalized singular
value decomposition (GSVD) for simultaneously identify-
ing relevant inﬂuences common to only copy numbers, gene
expression, or both measurements in conjunction. These
groups are reported and gene ontology (GO) annotations
are used as a functional assessment of the groupings ac-
companied by probabilistic signiﬁcance obtained by com-
binatorics. We illustrate this method for two independently
published studies of pancreatic cancer and breast cancer,
where public gene expression and DNA copy number data
is provided and measured across numerous tumor cell lines.
1. Introduction
The use of gene expression and copy number data is
combined for analyzing two separate cancer studies under
the GSVD framework. We locate speciﬁc inference patterns
and processes common to both genome-wide input mea-
surements across 10k unique clones. Our results suggest
that several genes are characterized as having strong inﬂu-
ences by both copy number variation and differential gene
expression and lists of about 100 genes were compared to
the cancer literature for both types of cancers. Preliminary
analysis of gene inﬂuence is assessed by using GO annota-
tions for each reported group of genes. Accordingly, these
genes are likely to be closely involved in cancer develop-
ment and progression, and could be promising targets for
therapeutic intervention.
¤ This work was supported in part by a University of California MICRO
grant with matching support from Philips Research Laboratories and
in part by Microsoft Corp.
2. Results
Two publicly available data sets were separately uti-
lized in this study of the effectiveness of the GSVD. Four-
teen breast cancer cell lines (BT-20, BT-474, HCC-1428,
Hs578t, MCF7, MDA-361, MDA-436, MDA-453, MDA-
468, SKBR-3, T47D, UACC-812, ZR-75-1, and ZR-75-30)
were selected for analysis of copy numbers and gene ex-
pression proﬁles using cDNA microarrays. Each breast can-
cerslidecontained13,824originalcDNAclonesbeforepre-
processing. Details on the microarray protocols, image pro-
cessing, cell line labels, and the original data are given in
Hyman et al. [4]. In addition, thirteen pancreatic cancer
cell lines (AsPC-1, BxPC-3, Capan-1, Capan-2, CFPAC-1,
HPAC, HPAF-II, HS 700T, Hs 766T, MIA PaCa-2, PANC-
1, SU.86.86, and SW 1990) were selected for analysis of
copy numbers and expression proﬁles. Each pancreatic can-
cer slide contained 12,232 transcripts before preprocessing.
Further information is provided by Mahlam¨ aki et al. [5].
Multi-input data was carefully preprocessed as follows.
If data from either cancer study was missing from one or
more samples in either gene expression or copy number
data, that transcript was removed across all samples. No
missing data in this study was estimated or inferred. Data
was further processed by DEARRAY software where unre-
liable ratios were discarded. Consequently, over half of the
transcripts from both cancer experiments were eventually
discarded across all samples.
2.1. Generalized Singular Value Decomposition
The GSVD is the simultaneous linear transformation of
two data sets Ra 2 RNa£m with Na ¸ m and Rb 2
RNb£m to the reduced m £ m space [3],
UTRaX = C = diag(c1;:::;cm) ci ¸ 0;
VTRbX = S = diag(s1;:::;sm) si ¸ 0: (1)
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paring the expression proﬁles of two completely different
genomes by Alter et al. [1]. For comparative cDNA and
CGH analysis, we are concerned with generalizing the SVD
to two matrices with the same number of rows (genes) and
columns (samples), Ra;Rb 2 RN£m, i.e.Na = Nb = N.
Hence, for each transcript we have expression measure-
ments in Ra and copy number measurements in Rb across
m cell lines. Correspondingly in Eq. (1), the matrices U and
V are real, orthogonal N £ m matrices and X 2 Rm£m is
a shared, invertible matrix.
We assume that the m generalized singular value pairs
(ci;si) of C and S are ordered such that
c1 ¸ c2 ¸ ¢¢¢ ¸ cm; s1 · s2 · ¢¢¢ · sm: (2)
The ratios ¾i = ci=si, for i = 1;:::;m; are called the
generalized singular values. It follows that ¾i = (1 +
tanµi)=(1 ¡ tanµi) and in some situations, we need to
only use one angle µi to represent either a generalized sin-
gular value pair or a generalized singular value. An angular
distance of 0 indicates that genes may be of equal signiﬁ-
cance in both data sets, with ci = si. An angular distance
of §¼=4 indicates no signiﬁcance in the second data set rel-
ative to the ﬁrst, with ci À si, or in the ﬁrst relative to the
second ci ¿ si. The angular distances are arranged in de-
creasing order of signiﬁcance in the ﬁrst data set relative to
the second such that ¼=4 · µ1 · ¢¢¢ · µn · ¡¼=4.
For pancreatic cancer, we examined the projections of
data that were highly signiﬁcant to gene expression, µ1,
highly signiﬁcant to copy numbers, µ13, and relevant to
both, µ4. Expression and copy number values were sorted
and the top nt = 50 and bottom nb = 50 genes were se-
lected for gene ontology assessment for functional analysis.
In addition, for the breast cancer data we separately per-
formed the same analysis using the respective projections
of this data.
2.2. Gene Ontologies
The n interesting genes were assessed their relevance by
GO annotations as follows. For a given GO category F, a
gene is either in the category or not in the category. Sup-
pose that K out of the N reference genes and k out of the
n interesting genes are in category F. Ultimately, we want
to ﬁnd out what is the probability of these k genes selected
from n in F happening by chance. The probability that a cer-
tain category occurs k times just by chance in the list of se-
lected genes is appropriately modelled by a hypergeometric
distribution with parameters (N;K;n):
P(kjN;K;n) =
¡K
k
¢¡N¡K
n¡k
¢
¡N
n
¢ : (3)
Based on this, the p-value of having k genes or fewer in F
can be calculated by summing the probabilities of a random
list of K genes having k genes of category F:
p =
n X
i=k
¡K
i
¢¡N¡K
n¡i
¢
¡N
n
¢ : (4)
See [2] for further details. GO annotations were studied us-
ing GoMiner software by Zeeberg et al. [6].
3. Conclusions
For the pancreatic cancer data, our analysis shows that
the genes common to both gene over-expression and copy
number ampliﬁcation had high relevance to cell growth and
maintenance.Transcriptsthatwerehighlyinﬂuentialtoboth
gene under-expression and copy number deletion had high
relevance to defense response processes. From the lists of
genes selected under this criteria, we report very low p-
values for a few ontology categories, therefore the proba-
bilistic signiﬁcance of these associations by annotations is
high. Similar analysis was performed for the breast cancer
data set and we found transcripts that were jointly inﬂuen-
tial to both gene over-expression and copy number ampliﬁ-
cation. Further analysis is currently underway to verify our
lists of relevant genes in the context of pancreatic and breast
cancer development and progression. Ultimately, we show
that the GSVD framework is highly useful for analyzing
genome-scale, multi-input data.
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